The 'In Silico Toxicology' Network Meeting 2020 will be held on 30 September 2020, 10am-5pm (UK time).
On Zoom this year, and open to all (max 300 participants) more details and registration here http://www.drugdiscovery.net/tox2020/.
An event (with free registration) to foster the In silico Toxicology Community in the UK and beyond. Scientific contributions are welcome as are those on ongoing work, regulatory aspects, industry perspectives, databases, relevant software, etc. in the field. This event is meant to stimulate interactions and discussions, hence speakers are asked to present both about successes and applications that work, as well as areas where still further work is needed, in order to truly develop the field in the future.
The SCI Fine Chemicals Group and RSC Chemical Information and Computer Applications Group are organising a second Workshop on Computational Tools for Drug Discovery. The meeting format will be the same as the very successful meeting run in Birmingham in 2019.
The 2020 workshop will be held on 19 May 2020 at Riverside West, Whitehall Road, Leeds , West Yorkshire, LS1 4AW.
The 2020 workshop will be held on 19 May 2020 at Riverside West, Whitehall Road, Leeds , West Yorkshire, LS1 4AW,
The Workshop Providers and Facilitators are
- Al Dossetter, MedChemica
- Greg Landrum, KNIME
- Gunther Stahl, OpenEye
- Ilenia Giangreco, CCDC
- Matt Segall, Optibrium
- Stuart Firth-Clark, Cresset
Attendees will be able to choose from 4 of 6 sessions.
To select which workshops you would like to attend for each session, please complete the survey on the website. Please note that spaces are allocated on a first-come, first-served basis.
More details of the workshops and registration details are on the website shown below
It has been over twenty years since Lipinski published his work determining the properties of drug molecules associated with good solubility and permeability. Since then, there have been a number of additions and expansions to these “rules”. There has also been keen interest in the application of these guidelines in the drug discovery process and how these apply to new emerging chemical structures such as macrocycles. This symposium brought together researchers from a number of different areas of drug discovery and provided a historical overview of the use of Lipinski’s rules, as well as looking to the future and how we use these rules in the changing drug compound landscape.
The 20 Years of the Rule of Five Meeting brought together researchers from a number of different areas of drug discovery and provided both a historical overview of the use of Lipinski’s rules, as well as looking to the future and how these rules might evolve in the changing drug compound landscape. The meeting had a capacity attendance of over 100, with Sygnature kindly providing the venue. The audience was a nice mix of industry “veterans”, students and those new to the industry. The meeting format was a morning session giving a historical viewpoint followed by a panel discussion, and the afternoon was dedicated by a more forward looking session again followed by a panel discussion.
The full report is here in PDF format Full Report, many thanks to the presenters for permission to use the images.
More details and the available slide decks are here, Twitter hashtag - #RuleofFive2019.